Issue 17 Spring 2010 22/3/10 15:13 Page 19
Article MEETINGS
Figure 4. Post Op x-ray after corpectomy, replacement with an interbody spacer, autologous graft and a lateral plate.
19-20 October Specialty Skills in Emergency Surgery and Trauma Venue: London, UK
www.rcseng.ac.uk Contact:The Royal College of Surgeons of England E-mail:
generalsurgery@rcseng.ac.uk Tel: +44 (0) 20 7405 3474
31 October - 4 November 38th
Annual Meeting of the
International Society for Pediatric Neurosurgery Venue: Jeju, Republic of Korea Contact: Conference Secretariat E-mail:
ispn@broad-water.com Tel: +630 681 1040
November 2010
4-6 November 5th
International Symposium on ger of neurological injury15 . The exertion
of the lesion and the replacement by a ti- tanium cage and ilac gaft was considered to be a better mechanical solution for the patient, besides the fact that we intended to have a curative procedure. Nevertheless a new recidiva was diagnosed one year later. An en bloc excision would probably have been more appropriate, but at the time we were not performing this routinely. Nevertheless, this proved to be at least partially a correct decision because the pa- tient became assymptomatic and was able to resume working [she is still working and with no clinical complaints]. One could argue that she should have had chemotherapy with MIBG imediately after the removal of the vertebral metas- tasis because it was the second recidiva, but it was decided against that in group reunion. It was taken in consideration that chemotherapy does not seem to increase the survival in women with metastatic ma- lignant paraganglioma16
Microneurosurgical Anatomy (5th ISMA) Venue: Istanbul,Turkey
www.isma2010.org Contact: Secretariat E-mail:
isma@isma2010.org Tel: +90 312 440 5600 Fax: +90 312 440 5597
9-12 November 7th
Interdisciplinary World
Congress on Low Back & Pelvic Pain Venue: Los Angeles,CA, USA
www.ucsd.edu Contact: UCSD CME E-mail:
ocme@ucsd.edu
When the local vertebral recidiva oc-
curred it was decided that the patient would undergo MIBG treatment. This option led to a regression in tumour size. Even in this perpective the surgical procedure was benefic to the patient because the dose of MIBG used is size dependent. The patient’s direct family was offered
Tel: +1 858 534 3940 Fax: +1 858 822 5908
13-18 November 10th
Asian-Oceania International
genetic screening, having been diagnosed 5 positive patients, and one already died of metastatic pheocromocytoma17
If you would like your event listed free of charge in Meetings, please forward details to:
The Editor, Spinal Surgery News, 2 Cheltenham Mount, Harrogate HG1 1DL
Tel: +44 1423. 569676 Fax: +44 1423 569677 E-Mail:
editor@spinalsurgerynews.com If you would like to reproduce our list, please place an acknowledgement to SSN in your text.
Conclusions This case outlines the clinical course of a pa- tient with a PGL type 4 syndrome for whom a rare vertebral metastasis was diagnosed. The case highlights the importance of offering targeted genetic testing for the SDHB gene mutations to a patient with multiple, extra- adrenal paragangliomas and a family history of malignant paraganglioma. It also illustrates the importance of identifying patients with germline SDHB mutations, as these patients are at a high risk of developing malignant dis- ease. On the other hand it also highlights the importance of a multidisciplinary approach to
Congress on Skull Base Surgery (AOSBS) in conjunction with WFNS Skull Base Course, Asian Australasian Society of Neurological Surgeons (AASNS) Course and World Academy Venue: Bali, Indonesia Contact: Santi Anwar E-mail:
aosbs2010@pharma-pro.com Tel: +62 21 5596 0180 Fax: +62 21 5596 0179
.
Subscribe today
SpinalSurgeryNews Evolution
spinalsurgerynews.com Winter 2008 Zimmer® Dynesys® Top-Loading
Proven performance of the Dynesys System with the versatility to meet individual surgeon preferences and complex operative needs.
SpinalSurgeryNews
spinalsurgerynews.com Spring 2009
Dynamic stabilization surgery: The new world of Zimmer Spine.
SSN is FREE for all spinal healthcare professionals
Top-loading cannulated screws Ergonomical Unique instrumentation
Familiar posterior approach with dynamic stabilization
Flexiblematerials stabilize the spine Preserves anatomical structures Also in HA-coated version
The difference is in the design and the approach
£24 for UK residents £32 for Europe £42 for Overseas
Zimmer Spine P.O. Box/Sulzer Allee 8, 8404 Winterthur, Switzerland Telephone +41(0) 52 262 6070 Fax
+41(0) 52 262 0139 e-mail
spine@zimmer.com
In the U.S., the safety and efficiency of this device for the indication of spinal stabilization without fusion has not been established.
www.zimmerspine.eu
Zimmer Spine 23, Parvis des Chartrons 33080 Bordeaux Tel : +33 5 56 00 18 20 Fax : +33 5 56 00 18 21 e-mail
spine@zimmer.com
SpinalSurgeryNews VCF TREATMENTMADE EASY
spinalsurgerynews.com Autumn 2009 SpinalSurgeryNews
spinalsurgerynews.com Spring 2010
Call: +44 (0)1423 569676 Email:
gaye@spinalsurgerynews.com Web:
www.spinalsurgerynews.com
Wallis® Posterior dynamic stabilization system
14 years of proven clinical evidence
in flexion and extension.
CERAMENT™ CE-mark pending. Not available for sale in the US. |SPINE SUPPORT
With CERAMENT™|SPINE SUPPORT, which is intended for use in vertebral compression fractures (VCF), BONESUPPORT™ has developed the unique treatment alternative, Ceramic Vertebral Augmentation (CVA). The new CVA-treatment is made possible through the combination of patented materials and mixing and delivery systems technology. It offers a range of benefits, among the more important are: Radiopaque. CERAMENT™ is easily traced in fluoroscopy. High penetrability. Bone is uniformly reinforced and held in position for future bone ingrowth. Non-exothermic.A biocompatible setting temperature. Fully biocompatible. Naturally controlled bone ingrowth. Calcium sulfate is gradually resorbed, leaving space for bone ingrowth, while the hydroxyapatite armors the osteoporotic bone. Osteoconductive. Bone healing in voids is enhanced.
www.bonesupport.com ceramic vertebral augmentation
“Clinical evaluation of a lumbar interspinous dynamic stabilization device (theWallis system) with a 13-year mean follow-up” Sénégas J, Vital JM, Pointillart V, Mangione P; Neurosurg Rev (2009) 32:335-342.
“Long-term actuarial survivorship analysis of an interspinous stabilization system” Sénégas J, Vital JM, Pointillart V, Mangione P; Eur Spine J (2007) 16:1279-1287.
“New interspinous implant evaluation using an in vitro biomechanical study combined with a finite-element analysis” Lafage V, Gangnet N, Sénégas J, Lavaste F, SkalliW. SPINE (2007) 32(16):1706-1713.
visitwww.zimmerspine.eu
Autumn 2012 | SpinalSurgeryNews | 23 Spring 2010 | SpinalSurgeryNews | 19
UK £6.00
UK £6.00
UK £6.00
UK £6.00
o B
9 0 S
A S t
a s u
t i s
h t o
i V
1 0 3
Come see us at BritSpine
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36